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Introduction
Autoimmune responses against the heart and infections
with cardiotropic viruses have been suggested to play a
major role in the pathogeneses of idiopathic dilated car-
diomyopathy (DCM). The interaction and cross-talk
between these complex mechanisms is not completely
understood, making etiologic distinction difficult.
Aim
We compared the prevalence and quantity of cardiotro-
pic viruses in heart tissue of DCM patients with and
without a previously diagnosed immune mediated
inflammatory disorder (IMID).
Patients and methods
Myocardial tissue samples and serum was obtained from
159 consecutive patients with DCM and 20 controls.
Patients were subdivided into groups based on the
absence (n=125) or presence (n=34) of an IMID, and
controls (n=20).
Results
The IMID patients showed elevated serum soluble inter-
leukin-2 receptor and neopterin compared to the non-
autoimmunity patients and controls, compatible with
the fact that these patients had an increased cellular
immune activation related to their IMID.
The non-IMID group revealed a higher PVB19 preva-
lence (100/125) compared to the autoimmunity patients
(16/34, p=0.04) and controls (11/20, p=0.02) and PVB19
copy numbers (561 ± 97 vs. 191 ± 92 copies/μgD N A ,a n d
103 ± 47 copies/μg DNA, respectively, both p<0.001).
Both the non-IMID and IMID DCM patients demon-
strated increased myocardial inflammation compared to
controls (12.5 ± 1.8 and 14.0 ± 3.2 vs. 5.1 ± 0.7 CD45-
positive inflammatory cells, both p<0.05).
Conclusion
Our data shows a similar PVB19 prevalence and load in
hearts of autoimmunity DCM patients and controls, but
increased prevalence and levels in non-autoimmunity
DCM patients. These findings suggest that ICM patients
i nt h ep r e s e n c eo fa nI M I Dh a v ead i f f e r e n tp a t h o p h y -
siologic mechanism compared to the virus-induced
form of ICM.
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